+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Pharmaceutical Market Access"

From
From
From
From
From
From
From
Rare Disease Drug Market Size, Share & Growth Report 2031 - Product Thumbnail Image

Rare Disease Drug Market Size, Share & Growth Report 2031

  • Report
  • October 2026
  • 582 Pages
  • Global
From
From
From
The Pharma Mini MBA (May 19-21, 2027) - Product Thumbnail Image

The Pharma Mini MBA (May 19-21, 2027)

  • Training
  • May 2027
  • 3 Days
  • Global
The Pharma Mini MBA (November 10-12, 2027) - Product Thumbnail Image

The Pharma Mini MBA (November 10-12, 2027)

  • Training
  • November 2027
  • 3 Days
  • Global
From
Loading Indicator

The Pharmaceutical Market Access market is a sector of the pharmaceutical industry that focuses on the commercialization of drugs and other healthcare products. It involves the development of strategies to ensure that products are available to patients and healthcare providers in a timely and cost-effective manner. This includes activities such as pricing, reimbursement, distribution, and promotion. Market access teams work to ensure that products are available to the right patients, at the right time, and at the right price. Companies in the Pharmaceutical Market Access market include AbbVie, AstraZeneca, Bayer, Boehringer Ingelheim, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more